CAS: 1261233-63-9 - 1,1-Dimethylethyl 4-(6-chloro-3-pyridazinyl)-2-methyl-1-piperazinecarboxylate
Formula:C14H21ClN4O2
InChI:InChI=1S/C14H21ClN4O2/c1-10-9-18(12-6-5-11(15)16-17-12)7-8-19(10)13(20)21-14(2,3)4/h5-6,10H,7-9H2,1-4H3
InChI key:InChIKey=YFAITYMWAJRUNA-UHFFFAOYSA-N
SMILES:O=C(OC(C)(C)C)N1CCN(C2=NN=C(Cl)C=C2)CC1C
- Sinonimi:
- 1,1-Dimethylethyl 4-(6-chloro-3-pyridazinyl)-2-methyl-1-piperazinecarboxylate
- 1-Piperazinecarboxylic acid, 4-(6-chloro-3-pyridazinyl)-2-methyl-, 1,1-dimethylethyl ester
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
1-Piperazinecarboxylic acid, 4-(6-chloro-3-pyridazinyl)-2-methyl-, 1,1-dimethylethyl ester REF: IN-DA000ROGCAS: 1261233-63-9 | - - - | Prezzo su richiesta | Mar 10 Dic 24 | |
4-(6-Chloro-pyridazin-3-yl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester REF: 3D-LAC23363CAS: 1261233-63-9 | Min. 95% | Prezzo su richiesta | Mar 21 Gen 25 | |
4-(6-Chloro-pyridazin-3-yl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester REF: 10-F090311CAS: 1261233-63-9 | 95.0% | - - - | Prodotto fuori produzione |
1-Piperazinecarboxylic acid, 4-(6-chloro-3-pyridazinyl)-2-methyl-, 1,1-dimethylethyl ester
CAS:1261233-63-9
Formula:
C14H21ClN4O2
Peso molecolare:
312.7951
Ref: IN-DA000ROG
Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024
4-(6-Chloro-pyridazin-3-yl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester
CAS:1261233-63-9
Please enquire for more information about 4-(6-Chloro-pyridazin-3-yl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester including the price, delivery time …
Formula:
C14H21ClN4O2
Purezza:
Min. 95%
Peso molecolare:
312.79 g/mol
Ref: 3D-LAC23363
5g | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
4-(6-Chloro-pyridazin-3-yl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester
CAS:1261233-63-9
Purezza:
95.0%
Peso molecolare:
312.79998779296875
Ref: 10-F090311
500mg | Fuori produzione | Richiedi informazioni |